Ph.D. William Benton Jones - 06 May 2024 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Issuer symbol
CRVS
Transactions as of
06 May 2024
Net transactions value
+$34,624
Form type
4
Filing time
07 May 2024, 17:06:34 UTC
Previous filing
08 Dec 2023
Next filing
23 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $34,624 +20,000 +15% $1.73 153,773 06 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Warrant (Right to Buy) Purchase +19,357 19,357 06 May 2024 Common Stock 19,357 $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.

Remarks:

SVP, Pharmaceutical Development